Molecular Health raises €25m from Dievini

With the fresh capital, Molecular Health plans to expand its commercial infrastructure and to increase the adoption of its product.

Earlier this month, Dievini participated in the €100m funding round of biotech company CureVac.

Previous funding
Including the most recent funding round, Molecular Health has raised €100m to date.

Company
Founded in 2004 and headquartered in Heidelberg, Molecular Health is a biomedical company that is transforming molecular data and medical knowledge into clinical information for targeted therapies. The company has additional sites in Boston and Houston in the US and employs 100 people. 

People
Friedrich von Bohlen is managing director at Dievini. Lutz Voelker is CEO of Molecular Health.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Expansion
• Healthcare
• Germany